StarFill Implant Plus Lidocaine presents a dermal filler based on cross-linked hyaluronic acid (HA). Starfill fillers are obtained using the “Zero Endotoxin and BDDE Entire Process” (ZEEP) technology, which guarantees minimized endotoxin and residual BDDE levels. The efficacy of the product use was confirmed by the Wrinkle Severity Rating Scale (WSRS) survey results of the assessment of wrinkle improvement on week 8, 16, and 24 after the injection procedure. High HA cross-linking degree ensures longer effect duration compared to other HA-based filler analogues on the market, while outstanding viscoelasticity and cohesiveness guarantee uniform extrusion force during injection, which means smooth and even filler distribution. The presence of lidocaine in the composition makes the procedure painless.
Strengths of StarFill:
the series contains products varying in the gel particle size depending on the scope of use
endotoxin level is below 0.1 EU/ml
high safety of the product due to maximized cross-linking efficiency and minimized residual BDDE
uniform particle size ensures even distribution of the filler during injection
long aesthetic effect duration
proven safety as demonstrated by the clinical safety assessment results
have CE certificate
StarFill Implant Plus Lidocaine is ideal for correction of severe lines and facial volumization. The filler is used for lower subcutaneous and supraperiosteal injections.
Scope of StarFill Implant Plus Lidocaine:
facial volumization (forehead, temples, malars, lower lid, chin, preauricular area, and jawline)
reduction of deep wrinkles and folds (nasolabial folds, worry lines, frown lines, perioral and chin wrinkles)
nose bridge/ridge improvement
The aesthetic effect lasts from 12 to 18 months.
Product composition: Cross-linked sodium hyaluronate 24 mg/ml, Lidocaine hydrochloride 3 mg/ml, PBS
StarFill Implant Plus Lidocaine
1 syringe × 1.1 ml, 2 needles per pack
Needle size: 27G